WeVote
Log In

Bill

Bill

SF 400

A bill for an act relating to schedule III controlled substances, and making penalties applicable.

2025-2026 Regular Session Introduced by Doug Campbell

Bill SF 400 classifies misoprostol, mifepristone, and methotrexate as Schedule III drugs, imposing felony penalties and fines for illegal handling, impacting healthcare access.

Subcommittee: Schultz, Blake, and Bousselot.
#abortifacients #controlledsubstances #drugs #felonies
0
WeVote Research Nonpartisan
Bill Summary · SF 400

Summary of Bill SF 400

Bill Number: SF 400
Title: A bill for an act relating to schedule III controlled substances, and making penalties applicable.
Status: Subcommittee: Schultz, Blake, and Bousselot
Introduced: February 20, 2025
Classification: Bill
Subject: Abortifacients, Controlled Substances, Drugs, Felonies

Purpose and Intent

Bill SF 400 aims to amend the classification of certain substances as Schedule III controlled substances under Iowa law. Specifically, it seeks to include misoprostol, mifepristone, and methotrexate in this category. The bill intends to regulate the manufacture, distribution, and dispensing of these substances, which are often associated with medical procedures related to abortion and other health treatments.

Key Provisions

  • Inclusion of Substances: The bill adds the following substances to the Schedule III controlled substances list:

    • Misoprostol: A medication used for various medical purposes, including abortion.
    • Mifepristone: Commonly used in medical abortions.
    • Methotrexate: Often used in cancer treatment and autoimmune diseases.

  • Penalties for Violations:

    • Individuals who manufacture, distribute, or dispense any of the newly classified Schedule III controlled substances will be committing a Class “C” felony.
    • In addition to the felony charge, offenders will face fines ranging from $1,000 to $50,000.

Impact

  • Affected Parties:

    • This legislation will primarily impact healthcare providers, pharmacies, and manufacturers involved in the handling of the specified controlled substances.
    • Patients seeking treatments involving these medications may also be affected due to potential changes in availability and access.

  • Legal and Health Implications:

    • The classification of these substances as Schedule III may lead to stricter regulations and oversight, potentially affecting how healthcare providers prescribe and dispense these medications.
    • The imposition of felony charges and significant fines may deter illegal distribution and misuse of these drugs.

Procedural Timeline

  • February 20, 2025: Bill introduced and referred to the Judiciary Committee.
  • February 25, 2025: Assigned to a subcommittee consisting of members Schultz, Blake, and Bousselot for further consideration.

This bill represents a significant shift in the regulation of certain medications, reflecting ongoing discussions about reproductive health and controlled substances within the legislative framework.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.